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Key points
 α- and β-cells express both Nav1.3 and Nav1.7 Na
+ channels but in different relative amounts.
 The differential expression explains the different properties of Na+ currents in α- and β-cells.
 Nav1.3 is the functionally important Na
+ channel α subunit in both α- and β-cells.
 Islet Nav1.7 channels are locked in an inactive state due to an islet cell-specific factor.
Mouse pancreatic β- and α-cells are equipped with voltage-gated Na+ currents that inactivate
over widely different membrane potentials (half-maximal inactivation (V0.5) at −100 mV and
−50 mV in β- and α-cells, respectively). Single-cell PCR analyses show that both α- and β-cells
have Nav1.3 (Scn3) and Nav1.7 (Scn9a) α subunits, but their relative proportions differ: β-cells
principally express Nav1.7 andα-cells Nav1.3. Inα-cells, genetically ablatingScn3a reduces the Na
+
current by 80%. In β-cells, knockout of Scn9a lowers the Na+ current by>85%, unveiling a small
Scn3a-dependent component. Glucagon and insulin secretion are inhibited in Scn3a−/− islets
but unaffected in Scn9a-deficient islets. Thus, Nav1.3 is the functionally important Na
+ channel
α subunit in both α- and β-cells because Nav1.7 is largely inactive at physiological membrane
potentials due to its unusually negative voltage dependence of inactivation. Interestingly, the
Nav1.7 sequence in brain and islets is identical and yet the V0.5 for inactivation is >30 mV more
negative in β-cells. This may indicate the presence of an intracellular factor that modulates the
voltage dependence of inactivation.
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Introduction
Insulin and glucagon are the principal hormones involved
in glucose homeostasis. They are secreted from the β- and
α-cells, respectively, of the pancreatic islets in response to
changes in plasma glucose levels, with insulin secretion
being stimulated and glucagon secretion being suppressed
by glucose elevation (Ashcroft & Rorsman, 2013). The
regulation of their release is impaired in diabetes mellitus:
insulin secretion is insufficient and glucagon levels are
inappropriately elevated (Dunning et al. 2005; Ashcroft &
Rorsman, 2012). In both cell types, electrical activity is
crucial for hormone release (Ashcroft & Rorsman, 2013).
This electrical activity is orchestrated by the concerted
activity of several different types of ion channel (Rorsman
et al. 2011).
Voltage-gated Na+ channels play a central role in cellular
excitability (Hille, 2001). They are dually influenced by the
membrane potential. A large rapid depolarization results
in Na+ channel opening and an inward Na+ current.
However, if depolarization is sustained, the channel enters
a non-conducting ‘inactivated’ state, resulting in a decline
in current flow. Thus, the magnitude of the Na+ current
depends on the potential at which the membrane normally
sits.
Mammalian Na+ channels consist of a pore-forming
α subunit and auxiliary β subunits that modify channel
gating (Catterall, 2000). There are nine different genes
(Scn1a-5a and Scn8a-11a) that encode Na+ channel α
subunits (Catterall et al. 2005). The channels resulting
from these genes are named Nav1.1–Nav1.9 (Goldin
et al. 2000). Confusingly, the numbers of the genes and
the protein do not always match. Thus, Nav1.6 and Nav1.7
are encoded by the genes Scn8a and Scn9a, respectively
(Goldin et al. 2000). Currently, four isoforms of the β
subunits are known: referred to as Scn1b, Scn2b, Scn3b
and Scn4b (Koopmann et al. 2006). With few exceptions
(Nav1.5, Nav1.8 and Nav1.9; Catterall et al. 2005),
voltage-gated Na+ channels are sensitive to the neurotoxin
TTX.
Pancreatic islet cells are equipped with TTX-sensitive
voltage-gated Na+ channels (Gopel et al. 2000a,b; Vignali
et al. 2006). Na+ channels are critical for glucose-induced
electrical activity and insulin secretion in human β-cells
(Pressel & Misler, 1990; Braun et al. 2008). However, their
role in rodent β-cells is puzzling because they exhibit an
arcane voltage dependence of inactivation. Surprisingly,
when holding at membrane potentials found under
physiological conditions, depolarisation evokes almost no
Na+ current in β-cells (Plant, 1988; Gopel et al. 1999; Lou
et al. 2003). By contrast, large Na+ currents can be evoked
in α-cells held at physiological membrane potentials and
blocking these channels with TTX slows the upstroke of the
action potential and inhibits glucagon secretion (Zhang
et al. 2013).
It has been proposed that the different inactivation
properties of Na+ currents in α- and β-cells are
attributable to different α or β subunit composition
(Lou et al. 2003). Here, we tested this hypothesis using
a combination of biophysical measurements of islet cell
Na+ currents and single-cell PCR analyses. The functional
significance of the different Na+ channel α subunits on
electrical activity and hormone secretion was dissected
using mice in which specific α subunits were genetically
deleted.
Our data confirm the important role of Na+ channels in
glucagon secretion, and provide evidence for a previously
unrecognised role for Na+ channels in insulin secretion.
They also raise the possibility that β-cells contain a factor
that shifts the voltage dependence of inactivation of Nav1.7
Na+ channels to hyperpolarised levels, rendering the
channel functionally inactive at physiological membrane
potentials.
Methods
Ethics
All animal experiments were conducted in accordance
with the UK Animals Scientific Procedures Act (1986) and
University of Oxford ethical guidelines. Human pancreatic
islets were isolated with ethical approval and clinical
consent at the Diabetes Research and Wellness Foundation
Human islet Isolation Facility (Oxford).
Animals
Unless otherwise indicated, all experiments were
performed using islets from C57BL/6 mice (wild-type).
Global Nav1.3 (Scn3a
−/−) knockout mice were generated
as described previously (Nassar et al. 2006). These
mice were healthy, fertile and grew as well as their
littermate wild type controls (Nassar et al. 2006). To
generate α- and β-cell-specific Nav1.7-deficient mice,
Scn9a+/L2 mice carrying one modified (L2) allele and
one wild-type allele (Nassar et al. 2004) were crossed
with mice expressing Cre-recombinase under the control
of the rat glucagon promoter (GlucCre+/tg; Herrera,
2000) or the rat insulin 2 promoter (RipCre+/tg; Postic
et al. 1999). The resulting Scn9a+/L2GlucCre+/tg or
Scn9a+/L2RipCre+/tg mice were mated with Scn9aL2/L2 mice
homozygous for the modified L2 allele. This gave rise to
α-cell-specific (Scn9aL2/L2GlucCre+/tg) and β-cell-specific
(Scn9aL2/L2RipCre+/tg) knockout mice (here referred to
as α-Scn9a−/− and β-Scn9a−/− mice, respectively) as
well as to littermate control animals Scn9a+/L2GlucCre+/tg
or Scn9a+/L2RipCre+/tg (referred to as α-Scn9a+/− or as
β-Scn9a+/−). The background mouse strain was C57BL/6.
The in vivo phenotype of the α- and β-cell-specific
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Scn9a−/− mice was not characterised but they were
not overtly diabetic, consistent with the mild effects on
secretion observed in vitro.
One series of experiments (see Fig. 5A) was performed
on tdRFP-negative cells in islets from mice expressing
the red fluorescent protein (tdRFP) under the control
of the somatostatin promoter (see supplementary
material in Chera et al. 2014). It was ascertained that
tdRFP-expressing cells contain somatostatin.
Preparation of pancreatic islets
Mice were killed by cervical dislocation, the pancreases
quickly removed and islets isolated by collagenase
digestion. Islets were used for acute experiments and were
not maintained in tissue culture for more than 16 h.
Whole-cell patch-clamp recordings
Whole-cell Na+ currents were recorded in α- and
β-cells within intact islets using the standard whole-cell
configuration as previously described (Gopel et al. 1999).
The measurements were performed using EPC-9 or
EPC-10 patch-clamp amplifiers and Pulse software (HEKA
Electronics, Lambrecht/Pfalz, Germany). Currents were
compensated for capacitive transients and linear leak using
a−P/4 protocol. The currents were filtered at 2.9 kHz and
digitised at >10 kHz.
The standard extracellular medium for the electro-
physiological measurements consisted of (mM) 118 NaCl,
20 tetraethylammonium-Cl (TEA-Cl), 5.6 KCl, 1.2 MgCl2,
5 Hepes (pH 7.4 with NaOH), 2.6 CaCl2, 5 D-glucose and
2 CoCl2 (to block Ca
2+ channels). The pipette solution
contained (mM) 120 CsCl, 1 MgCl2.6H2O, 1 CaCl2, 10
EGTA, 10 Hepes (pH 7.15 with CsOH) and 3 Mg-ATP.
TTX (Alomone Labs, Jerusalem, Israel) was used at a final
concentration of 0.1 µg ml−1.
Membrane potential recordings were performed as
described previously (De Marinis et al. 2010) using the
perforated-patch technique and K2SO4-filled electrodes.
In these experiments, the extracellular (Krebs–Ringer
buffer, KRB) solution consisted of (mM) 140 NaCl, 3.6
KCl, 0.5 MgSO4, 0.5 NaH2PO4, 2 NaHCO3, 5 Hepes, 1.5
CaCl2 and glucose as indicated. All electrophysiological
experiments were performed at 34°C.
Hormone measurements
Batches of 10–20 size-matched islets were preincubated in
0.3 ml of a modified KRB containing 1 mM glucose and
2 mg ml−1 BSA for 1 h at 37°C, followed by a 1 h test
incubation in 0.3 ml of the same medium supplemented
with glucose, receptor antagonists, metabolic inhibitors
and ion channel activators/blockers as indicated. Insulin
and glucagon were assayed using Millipore RI-3K
(Billerica, MA, USA) and Eurodiagnostica RB 306
(Malmo¨, Sweden) radioimmunoassays, respectively. The
somatostatin receptor (SSTR) antagonist BIM23056 was
obtained from Tocris (Bristol, UK).
Pancreas perfusion
Dynamic measurements of insulin secretion were
performed using in situ pancreatic perfusion. Briefly,
the aorta was cannulated by ligating above the coeliac
artery and below the superior mesenteric artery, and
the pancreas was perfused with KRB solution at a
rate of 0.45 ml min−1 using an Ismatec (Glattbrugg,
Switzerland) Reglo Digital MS2/12 peristaltic pump.
The perfusate was maintained at 37°C with a Warner
Instruments temperature control unit TC-32 4B in
conjunction with a tube heater (Warner Instruments P/N
64-0102, Hamden, CT, USA) and a Harvard Apparatus
(Holliston, MA, USA) heated rodent operating table. The
effluent was collected, using a Teledyne (Thousand Oaks,
CA, USA) ISCO Foxy R1 fraction collector, by cannulating
the portal vein. The pancreas was first perfused for 20 min
with 1 mM glucose before commencing the experiment to
establish the basal rate of secretion.
[Ca2+]i imaging
Confocal [Ca2+]i imaging experiments were conducted
essentially as previously reported (Girard et al. 2009).
Islets were superfused with the KRB described above plus
glucose and TTX or tolbutamide as indicated, at a flow
rate of 1 ml min−1 and 37°C.
Identification of α- and β-cells in intact islets
In all voltage-clamp experiments, the identity of theα-cells
was established by immunocytochemistry following
injection of the cell with biocytin (0.5 mg ml−1)
via the recording electrode (Zhang et al. 2007).
In the membrane potential recordings, α-cells were
identified based on their spontaneous action potential
firing with 1 mM glucose; β-cells were identified as
cells that were electrically silent and hyperpolarized
with 1 mM glucose and had characteristic oscillatory
electrical activity when exposed to 8 mM glucose (Gopel
et al. 2000a). Cells identified by these criteria had Na+
channel inactivation properties characteristic of α- and
β-cells, as indicated by voltage-clamp measurements in
cells identified by immunocytochemistry. For [Ca2+]i
measurements, β-cells were identified by the induction
of [Ca2+]i oscillations at 6 mM glucose that convert into a
(more) sustained [Ca2+]i elevation at 20 mM glucose.
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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RNA purification and quantitative RT-PCR
RNA purification and quantitative RT-PCR in mouse
islet cells were carried out as described elsewhere (Braun
et al. 2009, 2010). Details of primer sequences used
will be provided on request. Some experiments were
performed using mRNA collected from α- and β-cell
fractions purified by fluorescence-activated cell sorting,
as described previously (De Marinis et al. 2010)
Preamplification and single-cell RT-PCR
Individual cells were collected using 2µl 0.5% NP-40 lysis
buffer. cDNA was synthesized as above with a reaction
volume of 10 µl (Bengtsson et al. 2005; Stahlberg &
Bengtsson, 2010). Single-cell cDNA was preamplified
for 10 cycles with the TaqMan PreAmp Master Mix
Kit (PN4364130, Applied Biosystems, Foster City, CA,
USA) and TaqMan assays according to the manufacturer’s
instructions. In the subsequent quantitative PCR (qPCR),
2.5µl preamplification product diluted 1:20 was used. The
presence of transcript was defined as a positive signal from
the TaqMan probe after 40 PCR cycles. Amplicon size was
confirmed by agarose gel electrophoresis.
Identification of Scn9a splice variants in mouse islets
Total RNA purified from mouse islets and brain was
reverse-transcribed using a High Capacity RNA-to-cDNA
Kit (Applied Biosystems). PCR was performed with Scn9a
gene-specific primers and the resulting PCR products
were cloned using a Zero Blunt TOPO PCR cloning kit
(Invitrogen, Carlsbad, CA, USA) and sequenced.
Data analysis
All data are given as mean values ± SEM of the indicated
number of experiments (n).
All electrophysiological experiments were performed on
the indicated number of cells obtained (unless otherwise
stated) from at least three different animals (usually
more). Current amplitudes have been normalised to cell
capacitance and are expressed as pA pF–1. Inactivation
was analysed by applying 200 ms conditioning pulses
(from −180 to −5 mV) followed by a test pulse to 0 mV
(applied at a frequency of 1 Hz). Peak current amplitude
during the test pulse (I) was normalized to that observed
when the conditioning pulse went to −180 mV (Imax).
Data are presented as h (= I/Imax). The Na
+ current
activation parameters were determined as described pre-
viously (Gonoi & Hille, 1987): the Na+ conductance (G)
was calculated from the measured Na+ current amplitudes
(I) by the relationG= I/(V−Vr) whereV is the membrane
potential andVr is the estimated reversal potential (Nernst
potential), calculated from the extra- and intracellular Na+
concentrations in media used. Values ofG at a givenVwere
normalised to the maximal G (Gmax). Inactivation and
activation curves were fit to single or double Boltzmann
functions as appropriate. Peak current amplitudes, the
activation (τm) and inactivation (τh) time constants,
and inactivation properties were estimated using the
electrophysiology analysis software package Pulsefit (Heka
Electronics. Lamprecht/Pfalz, Germany).
Action potential peak voltages were measured as
reported elsewhere (Zhang et al. 2013); the number of
action potentials for each experimental condition/cell
averaged >40.
Statistical significances were evaluated using Student’s t
test or ANOVA (for multiple comparisons), as appropriate.
Results
Molecular characterization of Na+ channel subunits in
mouse and human pancreatic islets
In mouse pancreatic islets, Scn9a was the dominant α
subunit, being expressed at levels 6-fold higher than Scn3a
and Scn8a. Of the β subunits, only Scn1b and Scn3b were
detected (Fig. 1A). The high expression of Scn9a and Scn1b
in islets is in agreement with a previous report (Ernst
et al. 2009).
We performed single-cell PCR to determine which sub-
units are expressed inα- andβ-cells, respectively (Fig. 1B).
All cells used for this analysis possessed voltage-gated
Na+ currents, as confirmed by whole-cell patch-clamp
recordings prior to mRNA collection. Yet most cells (40
out of a total of 52 β-cells and 24 out of a total of 37
α-cells, from three mice) lacked detectable mRNA for any
of the Na+ channel α subunits, perhaps due to low mRNA
copy numbers and/or non-continuous gene transcription
(Raj et al. 2006). In those α-cells in which transcripts
were detected, Scn3a and Scn9a were found equally often.
Importantly, 2 of the 13 α-cells contained mRNA for both
Scn3a and Scn9a. In β-cells (Fig. 1B, lower), Scn9a was the
most abundant transcript (4.5-fold more frequent than
Scn3a). No β-cells and only one α-cell expressed Scn8a. Of
the β subunits, Scn3b was found 2.7-fold more often than
Scn1b in α-cells, whereas Scn1b predominated in β-cells
(detected 4.5-fold more often than Scn3b).
We also measured Na+ channel transcripts in pure α-
and β-cell fractions. In α-cells (Fig. 1C, top), Scn9a was
the most abundant transcript but relatively high levels
of Scn3a and Scn8a were also found. Among the β sub-
units,Scn3bwas predominantly expressed (>4-fold higher
than Scn1b). In β-cells (Fig. 1C, bottom), Scn9a was
expressed at levels 7- to 20-fold higher than Scn8a and
Scn3a, respectively, and Scn1b was expressed at 6-fold
higher levels than Scn3b. In agreement with the whole-islet
data, β subunits were expressed at much lower levels than
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Scn9a in both α- and β-cell fractions. Thus, the data
obtained from purified α- and β-cell populations are in
good agreement with those obtained from single α- and
β-cells.
Figure 1. Expression of Na+ channel subunits in pancreatic
islet cells
A, qPCR on mouse islets (n = 3 preparations). Data have been
normalized to expression of Scn9a, which in turn was normalised
against mean expression of ribosomal protein S29 (Rps29) and
hypoxanthine guanine phosphoribosyl transferase 1 (Hprt). B,
single-cell PCR analyses of α- (top) and β-cells (lower). Data are
presented as the percentage of α-cells (or β-cells) containing the
indicated Na+ channel transcript and come from 13 α-cells
(identified by the presence of glucagon mRNA), and 12 β-cells
(containing insulin mRNA). Cells come from three mice.
C, as in A but using pure α- (top) and β-cell fractions (lower).
Properties of Na+ currents in mouse α- and β-cells
As our PCR analyses indicated that α- and β-cells
may contain Na+ channels of different molecular
composition, we next investigated whether this might give
rise to biophysically distinct Na+ currents. All electro-
physiological data reported here were obtained from
identified α or β-cells in intact acutely isolated pancreatic
islets. In β-cells, two types of responses were observed.
In 70% of β-cells (7/10 cells), no Na+ current was seen
when the holding potential was −70 mV but large Na+
currents were evoked when the cells were subsequently
hyperpolarised to −180 mV. In the remaining β-cells
(n = 3), voltage-gated Na+ currents were elicited from
−70 mV that increased only 2-fold when the cells were
hyperpolarised to−180 mV. Figure 2A compares the mean
Na+ I–V relationship evoked from holding potentials of
−70 or −180 mV.
We analysed the voltage dependence of Na+ current
inactivation using a standard two-pulse protocol (Fig. 2B).
In mostβ-cells (n=7), inactivation was well described by a
single Boltzmann function with half-maximal inactivation
(V0.5) at −97 ± 1 mV. However, in the subset of cells
in which Na+ currents could be evoked from −70 mV,
inactivation was best described as a sum of two Boltzmann
functions with V0.5 at −97 ± 6 and −50 ± 1 mV,
comprising 49 ± 10 and 51 ± 10% of the maximum
current, respectively (n = 3). When the data from all 10
cells were pooled, inactivation was biphasic with V0.5 at
−95± 2 and−50± 1 mV, comprising 85± 8 and 15± 8%
of the maximum current, respectively (Fig. 2B).
In α-cells, large Na+ currents were invariably observed
when holding at −70 mV and hyperpolarization to
−180 mV only marginally increased (+20%) the peak
current amplitude (Fig. 2C). Figure 2C compares the I–V
relationships recorded when cells were held at −70 or
−180 mV. A biphasic inactivation curve was observed in all
6 cells analysed (Fig. 2D). The more negative component
had aV0.5 of−84± 5 mV and accounted for only 26± 3%
of the total Na+ current. The principal component
(comprising 74 ± 3%) had a V0.5 of −47 ± 1 mV.
Also shown in Fig. 2B and D are the Na+ current
activation curves. In α-cells, activation was monotonic
and half-maximal at −23 ± 2 mV (n = 6). In the sub-
set of β-cells where part of the Na+ current inactivated
at more positive membrane potentials, activation was also
monotonic and half-maximal at −23 ± 1 mV (n = 3).
The corresponding value in β-cells where all Na+ current
inactivated at more negative voltages (V0.5 −100 mV)
was −24 ± 3 mV (n = 7). The activation curve shown in
Fig. 2B is based on the data from all 10 β-cells.
The finding that all α-cells (and some β-cells) exhibit
biphasic voltage-dependent Na+ current inactivation
suggests that Na+ channel subunits with widely different
inactivation properties are coexpressed in individual
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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cells. This echoes the single-cell PCR measurements that
provided direct evidence for the expression of both Scn3a
and Scn9a within the same α-cell.
Families of voltage-clamp currents recorded from β-
and α-cells during membrane depolarisation from −180
to −20, −10 and 0 mV are shown in Fig. 3A and B. The
voltage dependence of the time constants of activation
(τm) and inactivation (τh) of the Na
+ currents in α-
and β-cells are compared in Fig. 3C and D. In both α-
and β-cells, inactivation became progressively more rapid
(seen as a decrease in τh) as the cells were depolarised. The
differences between α- and β-cells were subtle but τh was
higher in β-cells at voltages above −10 mV.
Role of Na+ channels in islet cell electrical activity:
effects of TTX
The inactivation properties of the β-cell Na+ currents
suggest that Na+ channels will be almost fully inactivated
at physiological membrane potentials in β-cells and thus
contribute little (if at all) to β-cell electrical activity and
hormone secretion. By contrast, Na+ channels are likely
to be functionally more important in glucagon-secreting
α-cells. We examined this idea by performing membrane
potential recordings from α- and β-cells within intact
pancreatic islets, using the perforated patch configuration
(in which cell metabolism remains intact).
Unlike β-cells, α-cells are electrically active at 1 mM
glucose (Zhang et al. 2013). Figure 4A shows α-cell action
potentials displayed on a slow (left) and expanded (right)
time base under control conditions, during application of
the Na+ channel blocker TTX (0.1µg ml−1) and following
washout of the toxin. TTX consistently reduced the peak
voltage of the action potentials: from+2± 5 mV (n= 6) to
−12±1 mV (P<0.01). Thus, Na+ channels are important
for the upstroke of the action potential in α-cells.
In β-cells, TTX had more variable effects. In 3 out of 6
cells, TTX barely affected action potential firing elicited by
8 mM glucose (Fig. 4B). However, in the remaining three
Figure 2. Properties of voltage-gated Na+ currents in α- and β-cells in intact islets
A, I–V relationships recorded from holding potentials of −70 mV (◦) or −180 mV (•) in β-cells (n = 10). Cells
were depolarised to voltages between −60 and +50 mV in 10 mV increments. Note that the more hyperpolarized
holding potential leads to the generation of large Na+ currents. B, voltage dependence of Na+ current inactivation
(h) and activation (G/Gmax) in β-cells. The curves represent a double Boltzmann fit to the data (n = 10). C and
D, as in A and B but experiments were conducted on α-cells (n = 6). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 for
differences between holding at –70 and –180 mV.
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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β-cells, TTX markedly reduced action potential amplitude
(Fig. 4C): peak voltage decreased from −8 ± 1 mV in the
absence to −20 ± 3 mV in the presence of TTX (n = 3;
P < 0.03, paired t test). When all six cells were averaged,
peak voltage decreased from−18± 5 to−24± 2 mV, but
this difference did not quite reach statistical significance
(P< 0.07, paired t test).
In the presence of 20 mM glucose (Fig. 4D), whenβ-cells
were permanently depolarised to a membrane potential
of −47 ± 1 mV, TTX reduced the peak action potential
voltage from −25 ± 7 to −29 ± 6 mV (n = 4; P < 0.05,
paired t test). Note that whereas slow membrane potential
oscillations sometimes persist in β-cells exposed to 20 mM
glucose (as exemplified by the cell shown in Fig. 4D),
the response to the higher glucose concentration more
often consists of nearly uninterrupted action potential
firing without lengthy repolarised electrically silent inter-
vals (not shown but see Kanno et al. 2002)
Effects of TTX on glucose-induced [Ca2+]i increases in
β-cells and insulin secretion
Inβ-cells, action potential firing culminates in the opening
of voltage-gated Ca2+ channels. We tested the effects of
glucose and TTX on β-cell [Ca2+]i by confocal imaging
in fluo4-loaded mouse islets (Fig. 5A). In most cells (104
out of 110 cells) in which [Ca2+]i was low and stable
at 1 mM glucose, increasing glucose to 6 mM did not
induce any [Ca2+]i oscillations whereas a subsequent
increase to 20 mM elicited a sustained elevation of [Ca2+]i
(Fig. 5A, i).
However, in a small subset of cells (n = 6), [Ca2+]i
oscillations were evoked by 6 mM glucose. In these cells,
addition of TTX reversibly reduced the frequency of the
[Ca2+]i oscillations from 2.0 ± 0.7 to 0.5 ± 0.2 min
−1
(P < 0.05) and decreased the area under the curve
(above baseline) by 72 ± 14% (P < 0.05). Increasing
glucose further, from 6 to 20 mM, resulted in a
more sustained elevation of [Ca2+]i (Fig. 5A, ii). The
frequency of the rapid [Ca2+]i oscillations observed at
threshold glucose concentrations, and their conversion
to a non-oscillatory sustained increase at higher glucose
levels, echos the effects of glucose on β-cell electrical
activity (Henquin & Meissner, 1984). In intact islets,
β-cells are electrically coupled by gap junctions and this
synchronises electrical activity and [Ca2+]i oscillations
in a KATP channel-dependent fashion (Rocheleau et al.
2006). Unlike what is seen at higher glucose concentrations
(Zhang et al. 2008), the [Ca2+]i oscillations observed
Figure 3. Voltage dependence of Na+ current amplitude and kinetics in islet cells
A, family of voltage-clamp currents evoked by depolarisations from −180 to −20, −10 and 0 mV in a β-cell. B,
as in A but currents were recorded from an α-cell. C, time constant of activation (τm) recorded from β-cells (•;
n = 5) and α-cells (◦; n = 5) during depolarisations to membrane potentials between −20 and +40 mV. D, as in
C but for the time constant of inactivation (τh).
∗P < 0.05.
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at 6 mM glucose were not well synchronised across the
islet (Fig. 5B). It is possible that this is a consequence
of the KATP channel activity being slightly greater in the
non-active cells and that the lower input resistance pre-
vents synchronisation of electrical activity mediated by
current spread via the gap junctions.
We acknowledge that we cannot exclude the possibility
that some of the cells responding to 6 mM glucose
were somatostatin-secreting δ-cells, which have a lower
threshold for secretion than β-cells. To test this possibility,
we performed experiments on islets from mice expressing
red fluorescent protein (tdRFP) under the control of
the somatostatin promoter. Some tdRFP-negative cells
(likely to be β-cells) responded to 6 mM glucose with
TTX-sensitive [Ca2+]i oscillations that converted to
a sustained elevation when glucose was subsequently
increased to 20 mM (Fig. 5A, iii). The oscillatory pattern in
tdRFP-positive cells (i.e. δ-cells) was rather different and
consisted of larger and more regular [Ca2+]i oscillations
that were easily distinguished from those seen in β-cells.
Interestingly, 30% of tdRFP-positive δ-cells exhibited
spontaneous [Ca2+]i oscillations at 1 mM glucose (Fig. 5A,
iv). Collectively, the data suggest that a small number of
β-cells are indeed active at 6 mM glucose.
We next examined the effects of TTX on insulin
secretion using the perfused mouse pancreas preparation
(Fig. 5C, D). Under control conditions, increasing glucose
from 1 to 6 mM evoked a transient 7-fold stimulation
of insulin secretion (Fig. 5C, D). It is likely that this
is released from the small subset of β-cells that show
Figure 4. Effects of TTX on α- and β-cell electrical activity
A, left, membrane potential recording from an α-cell in an intact mouse pancreatic islet exposed to 1 mM glucose
before and after addition of TTX (0.1 µg ml−1), as indicated. Right, examples of action potentials recorded before,
during and after TTX application shown on an expanded time base. B and C, left, membrane potential recordings
from β-cells in intact islets exposed to 1 or 8 mM glucose and TTX, as indicated. Examples of responses in which
TTX had little effect (B; n = 3) or where it suppressed glucose-induced electrical activity (C; n = 3). Right, examples
of action potentials (recorded at the time points indicated by the black and grey stars) recorded at 8 mM glucose
in the absence and presence of TTX. D, left, effects of TTX on β-cell electrical activity evoked by 20 mM glucose.
Right, examples of action potentials recorded at 20 mM glucose in the absence and presence of TTX (n = 4).
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Figure 5. Effects of TTX on [Ca2+]i and insulin secretion
A, [Ca2+]i responses recorded from single cells in intact islets. Glucose (1, 6 or 20G) and TTX were applied as
indicated above the top trace (same for all recordings). i, example of a cell that did not respond to 6 mM glucose
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[Ca2+] oscillations in 6 mM glucose (Fig. 5A, ii and
iii). Subsequent stimulation with 20 mM glucose evoked
an insulin secretory response that was >20-fold higher
than that elicited by 6 mM glucose (Fig. 5C, D). This
correlated with an 18-fold increase in the number
of cells showing [Ca2+]i oscillations. Thus, it seems
that much of the increase in glucose-dependent insulin
secretion reflects recruitment of additional β-cells. At
both 6 and 20 mM glucose, insulin secretion was strongly
inhibited by the Na+ channel blocker TTX: the inhibitory
effect averaged 74 ± 8 and 68 ± 7%, respectively
(Fig. 5D).
The strong suppression of glucose-induced insulin
secretion by TTX seen in the perfused pancreas
experiments (Fig. 5D) contrasts with the weaker effect
of TTX on glucose-induced insulin secretion found
in static incubations of isolated islets (Fig. 5E, left).
Somatostatin-secreting δ-cells possess large TTX-sensitive
voltage-gated Na+ currents (Gopel et al. 2000a). As
expected, δ-cells identified by expression of tdRFP
generated large (100 mV) over-shooting action potentials
when exposed to 20 mM glucose, and these were
reversibly suppressed by TTX (Fig. 5F). We reasoned
that TTX-induced suppression of somatostatin secretion
might result in relief from paracrine inhibition of insulin
secretion in static incubations (Renstrom et al. 1996;
Hauge-Evans et al. 2009). To test this hypothesis, we
compared insulin secretion in the absence and presence of
the SSTR subtype 5 (SSTR5) antagonist BIM23056 (SSTR5
is the predominant SSTR subtype in mouse β-cells;
Strowski et al. 2003). The SSTR5 antagonist stimulated
insulin secretion at 8 mM glucose by 50% (Fig. 5E, right).
While TTX had little effect in the absence of BIM23056, it
exerted a strong inhibitory effect (60%) in its presence.
By contrast, in the perfused mouse pancreas, BIM23056
did not increase glucose-induced insulin secretion (data
not shown).
Collectively, the data of Figs 4 and 5 suggest that
Na+ channels play a previously unrecognised role
in the initiation of β-cell electrical activity, [Ca2+]i
oscillations and insulin secretion. We next attempted
to establish the molecular identity of these Na+
channels.
Na+ currents in Scn3a+/– and Scn3a–/– α- and β-cells
Expression analysis (Fig. 1) suggests that Nav1.3 (Scn3a)
might contribute to the Na+ current in both β- and
α-cells. We examined this possibility by comparing α-
and β-cell Na+ currents in cells from heterozygous
Scn3a+/– (that contain one functional Scn3a allele) and
Scn3a−/− knockout mice (that contain no functional
alleles).
Figure 6A shows Na+ current I–V relationships for
Scn3a+/– and Scn3a−/− β-cells. The magnitude of the
Na+ current in Scn3a+/– β-cells was slightly smaller than
in wild-type β-cells (compare with Fig. 2A) but this
difference was not statistically significant. However, that
in Scn3a−/− β-cells was reduced by 35%. Figure 6B
compares the voltage dependence of Na+ current
inactivation in β-cells from Scn3a+/– and Scn3a−/− mice.
Biphasic inactivation was observed in 4 of the 7 Scn3a+/–
β-cells analysed: one component, accounting for 69±20%
of the current, inactivated with a V0.5 of−94± 5 mV and
a second component, comprising 31 ± 20%, inactivated
with a V0.5 of −49 ± 7 mV. In the remaining 3 cells,
inactivation was monophasic with a V0.5 of −94 ± 3 mV.
Mean data from all seven Scn3a+/– β-cells are shown in
Fig. 6B. These values are not significantly different from
those of wild-type β-cells (Fig. 2B). In Scn3a−/− β-cells,
but where 20 mM glucose elicited a sustained increase in [Ca2+]i. This trace is representative of 104 of 110 cells
in 9 islets from 4 different mice. ii, example of a cell that responded with TTX-sensitive [Ca2+]i oscillations when
exposed to 6 mM glucose (6 of 110 cells). Subsequent elevation of glucose to 20 mM resulted in a more sustained
increase in [Ca2+]i. iii, recording from a β-cell (identified by the absence of tdRFP fluorescence) in an islet from
an Sst-tdRFP mouse that generated [Ca2+]i oscillations at 6 mM glucose and a sustained [Ca
2+]i elevation when
glucose was increased to 20 mM. iv, recording from a δ-cell (identified by the presence of tdRFP fluorescence);
note the large, regular spontaneous [Ca2+]i oscillations at 1 mM glucose which are little affected by increasing
the glucose concentration (unlike what is seen in β-cells). B, poor synchronization of [Ca2+]i oscillations in β-cells
exposed to 6 mM glucose. The traces were taken from two β-cells in the same islet. The dotted vertical lines
indicate the peaks of the [Ca2+]i oscillations in cell 1. C, stimulation of insulin secretion by 6 mM (left) and 20 mM
(right) glucose in the absence (•; n = 8) or presence (◦; n = 9) of TTX (0.1 µg ml−1). Note the different ordinate
scales. The grey areas highlight the same data points displayed using the different ordinate scales. For clarity,
statistical significances are not shown. D, area under the curve (AUC) measured in response to 6 or 20 mM glucose
in the absence and presence of TTX (0.1 µg ml−1; as indicated). Note the different ordinate scales for 6 and
20 mM glucose. ∗P < 0.05 (n = 8–9). E, insulin secretion measured at 1 or 8 mM glucose (Glc) with or without
TTX in the absence (left) or presence (right) of 100 nM BIM23056 (n = 6–8 replicates using islets from eight mice).
∗∗∗P < 0.001 vs. 1 mM glucose alone; †P< 0.01 vs. 1 mM glucose and TTX; ‡‡P < 0.01 vs. 8 mM glucose; §§P< 0.01
vs. 8 mM glucose and BIM23056. F, reversible suppression of action potential firing by TTX in a tdRFP-expressing
δ-cell. Note stimulation of action potentials when glucose was increased from 1 to 20 mM (1G and 20G). TTX was
applied at a concentration of 0.1 µg ml−1 as indicated by the bold horizontal line.
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inactivation was invariably monophasic and occurred with
a V0.5 of −102 ± 2 mV (n= 18).
The amplitude of the Na+ current in Scn3a+/– α-cells
was slightly smaller than that observed in control animals
(compare Figs 2A and 6C) but this difference was not
statistically significant. Figure 6C shows I–V relationships
recorded from Scn3a+/– and Scn3a−/− α-cells using a
holding potential of −180 mV. Total ablation of Scn3a
reduced the maximum current by 85% compared to
that observed in Scn3a+/– α-cells.
As in wild-type α-cells (Fig. 2D), Na+ current
inactivation was biphasic in all Scn3a+/– α-cells (n = 11,
Fig. 6D). One component, comprising 24 ± 10%
of the total current, inactivated at negative voltages
(V0.5=−91± 2 mV) and another component, accounting
for 76 ± 10% of the total current, inactivated at more
positive voltages (V0.5 = −38 ± 2 mV). These values
are comparable to those observed in wild-type cells
(Fig. 2D). InScn3a−/− α-cells, the Na+ current component
inactivating at voltages above −50 mV was abolished and
the relationship was well described by a single Boltzmann
function with aV0.5 of−94±7 mV (n=5). However, there
was a hint of a small component of inactivation between
−90 and−50 mV that may represent Scn8a, expression of
which was detected in α-cells (see Fig. 1).
Influence of ablating Scn3a on Na+ current kinetics
We examined the consequence of Scn3a ablation on the
time constants of activation (τm) and inactivation (τh)
in α- and β-cells. Activation and inactivation kinetics
in Scn3a+/– α-cells were similar to those observed in
wild-type α-cells (compare Figs 7A and B and 3C and
D). Ablation of Scn3a slowed activation (increased τm;
Fig. 7A) and accelerated inactivation (reduced τh; Fig. 7B).
In β-cells, ablation of Scn3a did not measurably affect
Na+ current kinetics, presumably because Scn3a/Nav1.3
only accounts for a fraction (<20%) of the β-cell Na+
current.
Na+ currents in β-Scn9a−/− β-cells
We next measured Na+ currents after cell-specific
knockout of Scn9a (Nav1.7). Figure 8A shows I–V
relationships recorded from β-Scn9a+/– and β-Scn9a−/−
Figure 6. Effects of ablating Scn3a on Na+ currents in α- and β-cells
A, peak Na+ I–V relationships for Scn3a+/– (•; n = 6) and Scn3a− /− (◦; n = 12) β-cells. ∗P < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001 vs. responses in Scn3a+/– β-cells. B, voltage-dependence of Na+ current inactivation in Scn3a+/– (•;
n= 7) and Scn3a–/– β-cells (◦; n= 18). C and D, as in A and B but experiments were performed on α-cells (C: n= 4
for Scn3a+/– and n = 6 for Scn3a− /−; D: n = 11 for Scn3a+/– and n = 7 for Scn3a− /−). The curves are the best
fit of single (Scn3a− /−) and double (Scn3a+/–) Boltzmann functions to the data points. ∗P < 0.05 vs. Scn3a+/–.
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β-cells. All β-cells from β-Scn9a+/– mice contained large
Na+ currents (n = 8) with an amplitude comparable to
that observed in wild-type mice (compare Figs 2A and
8A). By contrast, Na+ currents were seen in only 5 of
the 14 β-Scn9a−/− β-cells and the average maximum peak
current in all 14 cells (including those lacking detectable
Na+ currents) was accordingly reduced by 85%.
Figure 8B compares the voltage dependence of Na+
current inactivation inβ-Scn9a+/– andβ-Scn9a−/− β-cells.
In most β-Scn9a+/– β-cells, there was a single component
of inactivation with a V0.5 of −100 ± 2 mV. However, a
small additional component (with a V0.5 of−49± 7 mV)
was seen in 4 of the 14 cells studied. This amounted to
<10% of the total current and gave rise to a very small
(5–10% of the total current) shoulder on the inactivation
curve at voltages positive to −80 mV. In β-Scn9a−/−
β-cells, the Na+ current inactivation could be described
by a single Boltzmann function and was half-maximal at
−66 ± 7 mV (n= 4).
Na+ currents in α-Scn9a−/− α-cells
We next measured Na+ currents after α-cell-specific
knockout of Scn9a. Figure 8C illustrates the I–V
relationships for Scn9a+/– and Scn9a−/− α-cells. Ablation
of Scn9a reduced the Na+ current amplitude by<10%; the
residual current inactivated with a V0.5 of −35 mV (data
not shown), in reasonable agreement with that obtained
for the principal Na+ current component observed in
wild-type α-cells (Fig. 2D). Na+ current activation and
inactivation kinetics inα-Scn9a+/– andα-Scn9a−/− α-cells
were identical (data not shown), presumably because Na+
current kinetics in α-cells are principally determined by
non-Nav1.7 channels (probably Nav1.3). We conclude that
Nav1.7 Na
+ channels contribute only marginally to the
α-cell Na+ current.
Influence of ablating Scn9a on Na+ current kinetics
Na+ current activation and inactivation kinetics in
β-Scn9a+/– and β-Scn9a−/− β-cells are compared in
Fig. 9. In β-Scn9a+/– β-cells, Na+ current kinetics were
comparable to those seen in wild-type β-cells (Fig. 3C
and D). Whereas the effects on inactivation (τh) were not
statistically significant, activation tended to be slower in
β-Scn9a–/– β-cells and τm measured at−10 mV increased
from 0.3 to 0.7 ms. No effects on Na+ current
kinetics were seen in α-Scn9a–/– α-cells (data not shown),
Figure 7. Activation and inactivation of Na+ currents in Scn3a+/– and Scn3a−/− α- and β-cells
A, time constant of activation (τm) recorded from Scn3a
+/– (•; n = 5) and Scn3a−/− α-cells (◦; n = 5) during
depolarisations to membrane potentials between −10 and +20 mV. B, as in A but measuring the time constant
of inactivation (τh).
∗P < 0.05 for difference between Scn3a+/– and Scn3a− /− α-cells. C and D, as in A and B but
experiments were made in β-cells (n = 5).
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presumably reflecting the small contribution of Nav1.7
Na+ channels to the α-cell Na+ current.
Effects of Scn3a and Scn9a ablation on glucagon and
insulin secretion
Our electrophysiological analyses reveal that Scn3a
encodes a Na+ channel (Nav1.3) that is active at physio-
logical membrane potentials and thus suggest that ablation
Figure 8. Effects of ablating Scn9a on Na+ currents in α- and
β-cells
A, peak Na+ I–V relationships for β-Scn9a+/– (•; n = 8) and
β-Scn9a−/− β-cells (◦; n = 15 from one mouse). ∗p < 0.05,
∗∗p < 0.01, ∗∗∗P < 0.001 vs. β-Scn9a+/– data. B, voltage
dependence of Na+ current inactivation in β-Scn9a–/– (◦; n = 9; from
one mouse) and β-Scn9a+/– (•; n = 15) β-cells. The curves are the
best fits of a single (β-Scn9a− /) or double (β-Scn9a+/–) Boltzmann
function to the data. C, as in A but for α-cells in α-Scn9a+/– (·;
n = 8) and α-Scn9a−/− islets (◦; n = 8). ∗P < 0.05 vs. α-Scn9a+/–.
of Nav1.3 channels will influence electrical activity and
hormone secretion in both α- and (some) β-cells.
Conversely, ablation of Scn9a, which encodes a Na+
current that inactivates at negative membrane potentials,
is predicted to have little (if any) effect on glucagon or
insulin secretion.
In Scn3a+/– islets, increasing glucose from 1 to 8 mM
inhibited glucagon secretion by >60% (Fig. 10A, left),
similar to what is observed in wild-type islets (not shown
here but see Macdonald et al. 2007). In Scn3a–/– islets
(Fig. 10A, right), glucagon secretion at 1 mM glucose was
reduced by two-thirds compared to that seen in Scn3a+/–
islets and although elevating glucose to 8 mM resulted
in further suppression, the magnitude of this effect was
reduced by 70%. The lower rate of glucagon secretion in
Scn3a-deficient islets was not due to a decreased glucagon
content, which averaged 939 ± 99 and 804 ± 23 pg per
islet in Scn3a+/– and Scn3a−/− islets, respectively (not
statistically different).
Whereas TTX inhibited glucagon secretion at 1 mM
glucose in Scn3a+/– islets, it was without inhibitory effect
in Scn3a−/− islets: if anything, it tended to stimulate
glucagon secretion (Fig. 10A), possibly reflecting relief
from paracrine inhibition (cf. Zhang et al. 2013).
Ablation of Scn9a in α-cells did not affect glucagon
secretion at either 1 or 10 mM glucose (Fig. 10B) and TTX
was equally inhibitory at 1 mM glucose in both control
Scn9+/– and Scn9a−/− islets (Fig. 10B).
In both Scn3a+/– and β-Scn9a+/– islets, glucose (8 or
10 mM) stimulated insulin secretion 3-fold (Fig. 10C
and D, left). However, glucose failed to stimulate insulin
secretion in Scn3a-deficient islets (Fig. 10C, right)
although it remained stimulatory in β-Scn9a−/− islets
(Fig. 10D).
Pancreatic islets do not express an islet-specific Scn9a
isoform
The inactivation of Nav1.7 Na
+ channels (encoded by
Scn9a) we observe in mouse β-cells occurs at voltages
30 mV more negative than reported for the same
channels in sensory neurones (Herzog et al. 2003).
One possible explanation for this discrepancy is that
β-cells and neurones express distinct Nav1.7 isoforms.
However, although two splice variants were detected in
both mouse islets and brain tissue, named isoforms A and
B (Fig. 11), their deduced amino acid sequences were 100%
identical.
Nav1.7 inactivation is controlled by an intracellular
islet cell factor
Nav1.7 heterologously expressed in HEK 293 cells
inactivates with a V0.5 of−70 mV (Cox et al. 2006), which
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is 30–40 mV more positive than we observe in β-cells.
The finding that Nav1.7 is identical in islets and brain
therefore suggests that islet cells contain a factor that shifts
Nav1.7 inactivation toward unphysiologically negative
membrane potentials. We tested the possible involvement
of a diffusible (cytosolic) factor by comparing Na+ current
inactivation in β-cells at various times after establishment
of the whole-cell configuration. We measured V0.5 as
−98 ± 1 and −104 ± 1 mV (n = 3; P < 0.02) at
2 and 15 min after starting the recordings, respectively
(Fig. 12A). It is evident that the shift is small and in
the opposite direction, and thus cannot explain why Na+
channel inactivation occurs at such negative voltages in
β-cells.
Na+ channel inactivation in human β-cells
Unlike rodent β-cells, Na+ currents in human β-cells
are reported to inactivate at physiological membrane
potentials (Misler et al. 1992; Braun et al. 2008). Recent
RNA sequencing data indicate that SCN9A represents a
small fraction (25%) of Na+ channel transcripts on human
β-cells (Nica et al. 2013). We therefore reassessed the
voltage dependence of inactivation in human β-cells. Two
components of inactivation were observed in 4 out of 9
human β-cells: one component accounting for 23 ± 3%
of the current inactivated with a V0.5 of−105± 2 mV and
a second component comprising 77 ± 3% with a V0.5 of
−41 ± 1 mV. In the remaining 5 cells, inactivation was
monotonic with a V0.5 of −46 ± 1 mV (Fig. 12B). The
contribution of the component inactivating at negative
voltage averaged 10 ± 4% of the total Na+ current when
data from all nine cells were combined. Its smallness
probably explains why it escaped detection in the earlier
study (Braun et al. 2008).
Discussion
Our data demonstrate that α- and β-cells express the
same types of voltage-dependent sodium channel α sub-
units: Nav1.3 (Scn3a) and Nav1.7 (Scn9a). Although Scn8a
(Nav1.6) is also expressed in both α- and β-cells, electro-
physiological data indicate that Nav1.6 channels do not
contribute substantially to the Na+ current in either cell
type.
Na+ channel density in the plasma membrane
(measured as the maximum Na+ current that can be
evoked from a hyperpolarized membrane potential) is
approximately equal for both cell types but Na+ currents
evoked from physiological resting potentials are far larger
in α-cells (100 pA pF–1) than β-cells (20 pA pF–1). The
reason for this difference is that the relative expression of
Nav1.3 and Nav1.7 differs, with Nav1.3 being expressed
at high levels in α-cells and Nav1.7 being the dominant
subtype in β-cells. Furthermore, Nav1.7 channels in
both α- and β-cells are locked in a functionally inactive
state, so that they contribute little to the physiologically
activatable Na+ current density. Thus, in β-cells, where
Nav1.7 dominates, little Na
+ current can be evoked from
physiological resting potentials. As a consequence, Nav1.7
plays a relatively minor functional role in β-cells, despite
the fact that it accounts for 80–90% of the transcripts.
In α-cells, by contrast, where Nav1.3 dominates, large
Na+ currents can be activated at physiological membrane
potentials (−60 mV) and blocking Na+ channels with TTX
abolishes the stimulation of glucagon secretion evoked by
low glucose (Zhang et al. 2013).
Mouse α- and β-cells express different Na+ channel
subunits: impact on Na+ channel inactivation
Although Scn9a/Nav1.7 is expressed in both α- and
β-cells (Vignali et al. 2006), we observed that Scn9a is
quantitatively far more important in β-cells than α-cells
Figure 9. Activation and inactivation of Na+ currents in β-Scn9a+/– and β-Scn9a− /− β-cells
A, time constant of activation (τm) recorded from β-Scn9a
+/– (•; n = 8) and β Scn9a− /− β-cells (◦; n = 4) during
depolarisations to membrane potentials between −10 and +20 mV. B, as in A but measuring the time constant
of inactivation (τh).
∗P < 0.05.
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(>80 vs. 45% of all Na+ channel transcripts, respectively).
In agreement with this finding, 80–90% of the β-cell
Na+ current flows through Nav1.7 channels, but only
10–20% of the α-cell Na+ current. Conversely, Nav1.3 is
more important in α-cells, in terms of both transcripts
(30–50%) and Na+ current density (70–90%). Thus, there
is a reasonable agreement between the electrophysiological
and molecular biological data.
Role of Na+ channels in β-cells
We found that the Na+ channel blocker TTX inhibited
electrical activity, [Ca2+]i and insulin secretion in
the perfused pancreas. These data are in apparent
disagreement with our previous finding that insulin
secretion is little affected by TTX in isolated mouse islets
(Macdonald et al. 2007). We attribute this discrepancy
to accumulation of secreted somatostatin during static
incubations of isolated islets, which leads to suppression
of insulin secretion. By blocking somatostatin secretion,
we hypothesise that TTX relieves the paracrine inhibition
of insulin secretion and that this effect masks the
suppression of insulin secretion produced by inhibition
of Na+ channels in β-cells. Indeed, when somatostatin
signalling in β-cells was pharmacologically prevented,
insulin secretion in isolated islets became TTX-sensitive
(Fig. 5E).
At first sight, a major role for voltage-gated Na+
channels in β-cell electrical activity and insulin secretion
seems unlikely given that the Na+ current is almost
fully (>90%) inactivated at −70 mV, which is close to
the most negative membrane potential attained in the
absence of glucose. However, 30% of β-cells possess
a component of Na+ current that inactivates only at
more positive potentials. Inactivation of this current
is half-maximal at −50 mV, which is comparable to
the plateau potential from which the action potential
originates at glucose concentrations 20 mM. Although
Figure 10. Effects of ablating Scn3a and Scn9a on insulin and glucagon secretion
A, glucagon secretion measured during 1 h static incubations at the indicated concentrations of glucose and TTX
from Scn3a+/– (left) and Scn3a− /− (right) islets (n = 6 replicates using islet from three Scn3a+/– and five Scn3a− /−
mice). ∗P < 0.05, ∗∗P < 0.01 vs. 1 mM glucose (same mouse strain) and ††P < 0.01 for comparison between
Scn3a+/– and Scn3a− /− islets. B, as in A but comparing α-Scn9a+/– (n = 11 replicates using islet from three mice)
and α-Scn9a− /− islets (n = 6 replicates using islets from five mice). ∗P < 0.05; ∗∗P < 0.01 vs. 1 mM glucose. C, as
in A but insulin was measured. ∗P < 0.05 vs. 1 mM glucose (same strain); †P < 0.05 vs. wild-type. D, as in C but
measurements were made in β-Scn9a+/– and β-Scn9a−/− islets (n = 5–6 replicates using islets from five Scn9a+/–
and seven Scn9a− /− mice). ∗P < 0.05 vs. 1 mM glucose (same strain).
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Figure 11. Predicted amino acid sequences of Nav1.7 α
subunits from mouse brain and islets
Amino acid sequences of splice variants of Scn9a from mouse brain
and pancreatic islets are shown as a Clustal W alignment. Alternative
mouse splice forms found in GenBank (NP_061340, 1975 amino
acids; and AAI72147, 1984 amino acids) are shown as references.
Identical residues are marked with asterisks. Putative transmembrane
this current is small compared to that which can be
evoked from hyperpolarised membrane potentials, its
magnitude is comparable to that of the voltage-gated
Ca2+ current. Thus, it is likely to contribute to action
potential firing. Indeed, we found that that action potential
height is reduced by TTX. Insulin exocytosis is steeply
voltage-dependent (Gopel et al.2004) and it is possible that
a 4–6 mV reduction of action potential height accounts
for much of the suppression of glucose-induced insulin
secretion produced by TTX at high (20 mM) glucose
concentrations.
Electrophysiological characterization of Scn3a and
Scn9a knockout mice suggests that Nav1.3 represents the
functionally important Na+ channel subtype in β-cells.
This conclusion is underlined by the strong reduction of
glucose-induced insulin secretion in Scn3a−/− islets. Na+
currents at physiological resting potentials are observed
in only 30% of β-cells, but it is possible that very small
Nav1.3 Na
+ currents (too small to be detected) may be
present in the remaining 70% of cells and contribute to the
initiation and upstroke of the action potentials. Because
of the high input resistance of the β-cell in the presence of
glucose (Ashcroft & Rorsman, 2004), even such small Na+
currents may have a dramatic depolarising effect on the
β-cell membrane potential. At high glucose concentrations
when KATP channel activity is low in all β-cells, initiation
of Nav1.3 Na
+ channel-dependent electrical activity in
a subset of cells may, via current spread through the
gap junctions, trigger Ca2+-dependent electrical activity
in neighbouring β-cells in which Nav1.7 Na
+ channels
are completely inactivated. These considerations suggest
that Nav1.3 channels, despite their low copy number,
may play a previously unrecognised modulatory role in
glucose-induced electrical activity and insulin secretion in
mouse β-cells.
In human β-cells, Na+ channels play a prominent role
in action potential generation and insulin secretion is TTX
sensitive (Misler et al. 1992; Braun et al. 2008). Our data
suggest that Nav1.7 is indeed present in human β-cells
and inactivates at hyperpolarised voltages (−105 mV).
However, consistent with the relatively low expression of
SCN9A in β-cells (25% of all Na+ channel transcripts;
Nica et al. 2013), it comprises only a small component
of the total current. The fact that non-Nav1.7 currents
segments (S1–S6) are highlighted with continuous lines on top.
Sequences of both Nav1.7 α subunit isoforms from islets were
identical to those expressed in brain and the GenBank sequence
AAI72147, except the region highlighted. Isoform A (isoA) contains
the sequence encoded by extended exon 12 (extension highlighted),
while isoform B (isoB) contains the sequence encoded by
conventional exon 12. Note that only the sequences of domain I and
the cytoplasmic loop between domains I and II are shown because
the rest of the protein is 100% identical in all isoforms.
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dominate in human β-cells can explain why their Na+
currents inactivate at physiological membrane potentials.
Ablation of Nav1.7 (Scn9a) in mice had little effect
on glucose-induced insulin secretion, consistent with the
fact that this current is completely inactivated at resting
membrane potentials. Thus, the physiological role of
Nav1.7, which accounts for 80–90% of the total Na
+
current, in β-cells is obscure.
Role of Na+ channels in α-cells
The effects of the Na+ channel blocker TTX on glucagon
secretion and α-cell electrical activity confirm that
voltage-gated Na+ channels are important for the upstroke
of the α-cell action potential. Application of TTX resulted
in a 15 mV reduction of action potential height (from
+2 to−12 mV). The inhibitory effect of TTX on glucagon
secretion in wild-type islets is quantitatively similar to that
Figure 12. Voltage dependence of inactivation in mouse and
human β-cells
A, as in Fig. 2B but using β-cells that only contained a Na+ current
component inactivating at negative membrane potentials. The
inactivation curves were recorded immediately after establishment of
the whole-cell configuration (•) and 15 min later (◦). Data are
mean ± SEM recorded in the same cells at two different times
(n = 3). B, voltage dependence of Na+ current inactivation in human
β-cells that contained one (•, n = 5) or two (◦, n = 4) components
of inactivation when cells were held at −180 mV. The curves
represent single (black) or double (grey) Boltzmann fits to the data
(all cells from one organ donor).
produced by genetically ablating Scn3a−/−. This argues
that Nav1.3 represents the functionally important Na
+
channel inα-cells. Because of the steep voltage dependence
of exocytosis in α-cells, the reduction in action potential
height produced by TTX can be expected to exert a large
inhibitory effect (75%) on exocytosis (Zhang et al. 2013),
sufficient to account for the suppression of glucagon
secretion.
As in β-cells, Nav1.7 is unlikely to contribute to action
potential firing or glucagon secretion because of its
inactivation properties. This idea is supported by the
finding that ablation of Nav1.7 has little effect on glucagon
secretion.
Human α-cells possess a similar complement of
Na+ channel subunits, and other ion channels,
to human β-cells (Ramracheya et al. 2010; Nica
et al. 2013). The question therefore arises as to
why glucose stimulates insulin secretion, but inhibits
glucagon secretion. We have argued elsewhere that
this is principally because the magnitude of the KATP
conductance is much smaller in α-cells (Ashcroft &
Rorsman, 2013; Zhang et al. 2013). As a consequence,
α-cells are electrically active at low glucose concentrations
and membrane potential-dependent inactivation of Na+
channels mediated by glucose will have a strong inhibitory
effect on electrical activity and glucagon secretion. In
β-cells Na+ channel inactivation also occurs, but the
stimulatory effect on glucose on electrical activity (and
thus secretion) dominates.
Why do β-cell Nav1.7 channels inactivate at
unphysiologically hyperpolarised potentials?
In β-cells, inactivation of Nav1.7 proceeds at such negative
voltages that very few (if any) of these channels remain
‘activatable’ at the normal resting potential (−70 mV).
Why this is the case is an enigma. Mouse Nav1.7
currents in dorsal root ganglion cells inactivate with
a V0.5 of −70 mV (Herzog et al. 2003), 30 mV
more positive than the corresponding value in β-cells.
This puzzling difference does not reflect expression of
a splice variant because the β-cell Nav1.7 sequence
is identical to that found in neurones. This argues
that there must be something in β-cells that shifts
inactivation towards negative membrane potentials. The
identity of this factor remains unknown. However, the
fact that Nav1.7 inactivation does not shift towards more
depolarised potentials following extended intracellular
dialysis suggests the involvement of a non-diffusible
factor.
We speculate that the atypical inactivation of Nav1.7
in islet cells results from the interaction of Nav1.7 with
a protein (or lipid) present in β-cells but not in neuro-
nes. We can exclude a role of Na+ channel β subunits
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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because inactivation of the Nav1.3-independent current
component (representing Nav1.7) was identical (V0.5 at
−100 mV) in α- and β-cells despite these two cell
types expressing β3 and β1 subunits, respectively. It is
notable that Nav1.3 and Nav1.6 (as suggested by the Na
+
current measurements in human β-cells; Fig. 12) channels
undergo voltage-dependent inactivation at physiological
membrane potentials. Thus, the impact of this modulation
appears specific for Nav1.7 channels. The nature of this
modulator remains to be determined. Nav1.7 channels
play a key role in pain sensation (Dib-Hajj et al. 2008),
and thus identification of the putative modulator might
provide a new target for therapeutic drugs directed at
alleviating pain.
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